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Evidence suggests that the phospholipase C/protein kinase C 
signal transduction system participates in the regulation of 
epidermal cell growth and differentiation. Psoriatic epider-
mis is characterized by hyperproliferation, defective differ-
entiation, and inflammation. In this report, we have deter-
mined the activity of phospholipase C - catalyzed hydrolysis 
of phosphatidylinositol-4,5-bisphosphate (PIP2) and 1,2-di-
acyl glycerol content in normal and psoriatic involved and 
uninvolved epidermis. 1,2-diacylglycerol is formed from 
phospholipase C-catalyzed hydrolysis of PIP2 and is the 
physiologic activator of protein kinase C. PIP2 hydrolysis 
was assayed in soluble and particulate fractions prepared from 
keratome biopsies of normal and psoriatic skin. lotallipids 
were extracted from normal and psoriatic epidermis and 1,2-
diradylglycerol (a mixture of 1 ,2-diacylglycerol and l-ether, 
2-acyl-glycerol) quantitated by enzyme assay. Because 1,2-di-
acy.lglycerol is a more potent activator of/rotein kinase C, 
the relative proportions of 1,2-diacyl an l-ether, 2-acyl-
glycerol in uninvolved and involved psoriatic epidermis were 
determined. This was accomplished by separation of acetate 
derivatives of 1 ,2-diacylglycerol and l-ether, 2-acyl-glycerol 
by thin layer chromatography. Soluble and membrane-asso-
ciated phospholipase C-catalyzed PIP2 hydrolysis were in-
I t is well recognized that extracellular mediators, such as hor-mones, growth factors, and cytokines, can exert profound influences on the functions of target cells. Recent investiga-tions have demonstrated that the binding of a variety of medi-ators to specific cell-surface receptors results in the rapid 
activation of phospholipase C, which catalyzes the hydrolysis of 
phosphatidylinositol-4,5-bisphosphate (PIPz) (reviewed in [1,2]). 
The products of this reaction are two intracellular second messen-
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creased 3.7 times (p < 0.001) and 3 times (p < 0.004), respec-
tively, in psoriatic involved compared to uninvolved and 
normal epidermis. 1,2-diradylglycerol content was also sig-
nificantly elevated (3 times, p < 0.01) in psoriatic involved 
versus uninvolved and normal epidermis. Analysis of the ace-
tate derivatives of 1 ,2-diradylglycerol in psoriatic uninvolved 
and involved epidermis revealed that 1,2-diacylglycerol was 
the major species (86% and 95%, respectively). There were 
no significant differences in either phospholipase C-
catalyzed PIP 2 hydrolysis or 1,2-diacylglycerol content be-
tween uninvolved and normal epidermis. 1,2-diacylglycerol 
purified from normal and involved psoriatic epidermis was 
capable of activating protein kinase C from normal epidermis 
in vitro. In epidermal slices, activation of protein kinase C by 
addition of 12-0-tetradecanoy I phorbol-13-acetate and 1,2-di-
acyl glycerol (1,2-dioctanoylglycerol) resulted in subse-
quently decreased protein kinase C activity, a process termed 
down-regulation. These data are consistent with the possibil-
ity that the elevation in lesional 1,2-diacylglycerol content 
may account, in part, for the previously reported reduction of 
protein kinase C activity in psoriasis (Horn, Marks, Fisher, et 
al: J Invest Dermatol 88:220 - 222, 1987). ] Invest Dermatol 
95: 428-435, 1990 
gers, 1,2-sn-diacylglycerol and inositol-l,4,5-trisphosphate (IP3). 
r 1,2~diacylglycerol activates protein kinase C [3] and IP3 releases 
intracellular stores of calcium, leading to increased free cytosolic 
calcium [4,5] . Activation of protein kinase C and increased free 
calcium act synergistically to initiate a cascade of biochemical reac-
tions that participate in cellular responses such as gene expression, 
protein synthesis, an9 secretion. Agonist-induced phospholipase C 
is thus the first enzyme to be activated in the bifurcating signal-
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transduction pathway that couples the recognition of extracellular 
stimuli by cell-surface receptors to the intracellular machinery that 
regulates fundamental biologic processes such as growth and differ-
entiation. 
Current evidence suggests that most, if not all, of the pleiotypic 
responses of cells to tumor promoting phorbol esters, such as TPA, 
are mediated by protein kinase C (reviewed in [6]). TPA mimics the 
biologic effects of agonist-induced phospholipase C activation on 
protein kinase C by virtue of its structural similarity to 1,2-diacyl-
glycerol [7,8]. Topical application ofTPA to rodent skin evokes an 
inflammatory hyperplastic response characterized by accelerated ter-
minal differentiation, increased DNA synthesis, and induction of 
ornithine decarboxylase and epidermal transglutaminase [9 -11]. 
Topical application of 1 ,2-diacylglycerol similarly causes increased 
DNA synthesis and ornithine decarboxylase activity [12] . In cul-
tured murine and human keratinocytes, exogenous phospholipase C 
mimics the effects of TP A and 1,2-diacylglycerol on growth and 
induction of ornithine decarboxylase and epidermal transglutamin-
ase [13,14]. These data suggest t.hat phospholipase C, through its 
ability to form 1,2-diacylglycerol and thus activate protein kinase 
C, plays an important role in the regulation of epidermal cell func-
tion. 
Psoriasis is a common derma to logic disease characterized by cuta-
neous inflammation, epidermal hyperplasia, and defective epider-
mal differentiation. It is noteworthy that many of the histologic and 
biochemical aberrations that occur in psoriasis are also evident in 
TPA-treated mouse skin [15]. This observation, along with the 
apparent importance of protein kinase C in the regulation of epider-
mal cell homeostasis, has led us to investigate the participation of 
the phospholipase C/protein kinase C signal-transduction pathway 
in psoriasis. To this end, we have quantitated phospholipase C-
catalyzed hydrolysis of PIP2 and 1 ,2-diacylglycerol content in nor-
mal, uninvolved, and involved psoriatic epidermis. 
METHODS 
Epidennal Samples Adult human epidermis was obtained from 
normal, psoriatic involved, and psoriatic uninvolved skin by kera-
tome biopsy as previously described [16]. The blade depth was set to 
0.2 mrn for normal and psoriatic-uninvolved epidermis and to 
0.4 mrn for psoriatic-involved epidermis . These settings allowed 
excision of the epidermis near the dermal epidermal junction as 
judged by histologic examination. The cellular composition ofker-
atome biopsies from normal or psoriatic-uninvolved skin is at least 
90% keratinocytes (the remainder being melanocytes, fibroblasts, 
and leukocytes). Biopsies of involved psoriatic skin include an addi-
tional4 - 5% infiltrating leukocytes, which are primarily T lympho-
cytes and neutrophils. All tissue donors gave informed consent and 
the protocol for obtaining epidermal samples was approved by the 
University of Michigan Institutional Review Board. 
Preparation of Soluble and Membrane-Associated Epider-
mal Phospholipase C Fresh epidermal samples were washed 
with 20 mM Tris (pH 7.4), 2 mM EDTA, 2 mM EGTA, 0.01% 
leupeptin (homogenization buffer), and cut into small pieces (ap-
proximately 2 mm square) with scissors. Tissue was then further 
disrupted by polytron and glass homogenization as previously de-
scribed [16]. The epidermal homogenate was centrifuged at 500 X g 
for 5 min and the supernatant further centrifuged at 100,000 X g 
for 1 h. The superna·tant was decanted and served as the source for 
soluble phospholipase C activity. The supernatant could be stored 
for a period of 1 month at - 20°C without loss of activity. The 
pellet was re-suspended iri 20 mM Tris/maleate (pH 7.4), 80 mM 
KCl 0 .001% leupeptin, and centrifuged as above. The washed 
membrane pellet was re-suspended in the washing buffer to a pro-
tein concentration of 1- 2 mg/ml and assayed for phospholipase C 
activity the same day. All procedures were conducted at 4 °C . 
Preparation of Epidermal Protein Kinase C Protein kinase C 
was partially purified from keratome biopsies of normal epidermis 
as previously described [16] . Briefly, keratome biopsies were ho-
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mogenized in 20 mM Tris (pH 7.5), 5 mM EGTA, 2 mM EDTA, 
0.01 % leupeptin. The homogenate was centrifuged at 100,000 X g 
for 1 h and the supernatant and pellet served as the sources for 
solub~e a~d membrane-assoc!ated protei~ kinase C, respectively. 
Prote1I1 kinase C 111 the particulate fraction was solubilized with 
Triton X-I00 (0.5%) for 30 min on ice and centrifuged as above. 
Both soluble and ':lembrane-associated activities were partially puri-
fied by dlethyla~11lnoethyl (DEAE) chromatography prior to assay. 
ThiS was necessitated due to the presence of substances in the crude 
extract that interfere with the assay. In the experiment described in 
Fig 6, TritonX-100 (0.5%) was included in the initial homogeniza-
tion buffer to obtain a single fraction containing the total soluble 
and membrane-associated protein kinase C activities. 
Assay of PLC-Catalyzed PIP2 Hydrolysis Phospholipase C 
activity was assayed with sonicated dispersions of PIP2/PE as sub-
strate [17]. The ratio of PIP2 to PE was 1 : 0.4 for assay of soluble 
phospholipase C activity and 1 : 3 for assay of membrane-associated 
activity. [3H]PIP2 (30,000 cpm/assayed) was added to a mixture of 
non-radioactive PIP2 and PE in chloroform and dried under a stream 
·of nitrogen. The lipids were suspended in 100 mM Tris/maleate 
buffer (pH 6.5), 100 mM NaCl by vortexing and sonicated for 2 
min. A typical reaction mixture contained 100 mM Tris/maleate 
(pH 6.5) , 75.uM PIP2, ImM CaCI2, and enzyme preparation 
(20 .ug) in a volume of200.u1. The mixture was incubated for 5 min 
at 30°C and the reaction stopped by addition of 1 ml chloroform/ 
methanol/HCl (100: 100: 0.6), followed by 0.3 ml IN HCI con-
taining 5 mM EGTA. After separation of the phases, 0.5 mI of the 
aqueous phase was counted. Identification of the water-soluble prod-
ucts as inositol phosphates was performed by ion-exchange chroma-
tography on Dowex lX-8 formate form [18]. 
Assay of Protein Kinase C Activity Epidermal protein kinase 
C was assayed by its ability to catalyze the transfer of (32P]ortho-
phosphate from P2P]ATP to histone [7]. The complete reaction 
mixture contained 20 mM Tris (pH 7.4), 40.ug histone, lOO.uM 
CaCI2, 2.ug phosphatidylserine, 0.4 .ug dioleoylglycerol, or 0.4 .ug 
epidermal DAG, 10 .uM [32P]ATP (5 X 1 05cpm), and partially puri-
fied epidermal protein kinase C in a total of 200.u1. Reaction mix-
tures were incubated for 5 min at 30 °C and terminated by the addi-
tion of 1 ml 25% trichloracetic acid. Precipitable radioactivity was 
collected on Whatman GF /C filters and measured by liquid scintil-
lation counting. Protein kinase C activity was calculated as the 
difference in radioactivity between complete reaction mixtures and 
those in which calcium and lipid were omitted. 
Extraction of Lipid from Human Epidermis Frozen kera-
tome biopsies from normal, uninvolved, and involved psoriatic epi-
dermis (approximately 300 mg wet weight) were crushed under 
liquid nitrogen with mortar and pestle. The pulverized tissue was 
transferred to a Tenbroeck homogenizer containing 3 m1 chloro-
form/methanol (1: 2) and homogenized with 20 strokes. Chloro-
form-/methanol-inso1uble material was removed by centrifugation 
at 500 X g for 10 min. Chloroform (1 ml) and water (1 ml) were 
added to the supernatant and the phases separated by centrifugation 
at 500 X g for 5 min. The lower chloroform layer was removed and 
washed twice with 2 ml 0.2 M KCI/methanol (1: 1). The washed 
chloroform was evaporated to dryness with a stream of nitrogen. 
This procedure extracts both 1,2-diacylglycerol and 1-ether, 2-
acyl-glycerol, which differ only in the linkage at the sn-l position, 
and are referred to collectively as 1,2-diradylglycerol. For measure-
ment of protein kinase C activation, the 1,2-diradylglycerol in the 
chloroform extract was purified by thin-layer chromatography on 
silica gel 60 plates developed in benzene/ chloroform/ methanol 
(80:15:5) [19]. 
Quantitation of Epidermal 1,2-diradylglyceroI 1,2-dira-
dylglycerol was assayed by the procedure of Preiss et al [19] with 
slight modification. This assay does not distinguish between 1,2-di-
acyl glycerol and 1-ether, 2-acyl-glycerol [20]. The dried chloro-
form extract from the epidermal samples was dissolved in lOO.u1 
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chloroform. Duplicate aliquots of 10 and 20.u1 were removed and 
evaporated under a stream of nitrogen. The dried lipids were solubi-
lized in 20.ul octyl-P-D-glucoside/cardiolipin (7.5% octyl-P-D-
glucoside,S mM cardiolipin in 1 mM DETAPAC) by sonication 
for 15 sec. Escherichia coli DAG kinase (0.02 units/assay) was incu-
bated with [y_32P)ATP (10 rnM) in 100 mM imidazole/HCl (pH 
6.6),100 mMNaCl , 25 mMMgCl2,and 2 mMEGTAat25 °Cfor 
20 min. The reaction mixture (80 .ul) was then added to the deter-
gent-so lubilized lipid and incubated for an additional 30 min at 
25 ° C. Reactions were terminated by addition of 3 ml chloroform/ 
methanol (1: 2). (32P)phosphatidic acid was extracted into chloro-
form and separated by thin-layer chromatography on silica gel 60. 
The area corresponding to phosphatidic acid was scrapped into a 
scintillation vial and counted. The amount of 1 ,2-diradylglycerol in 
the epidermal samples was calculated by comparison to a standard 
curve and normalized to sample protein and DNA content. 
Measurement of 1,2-Diacyl- and 1-Ether, 2-Acyl-Glyc-
erol 1,2-diradylglycerol was purified from uninvolved and in-
volved psoriatic epidermis by thin-layer chromatography as de-
scribed above. Epidermal 1,2-diradylglycerol and standards 
(1,2-dioleoylglycerol and 1-0-hexadecyl, 2-oleoylglycerol, 0.5-
2.0 .ug) were dried under a stream of nitrogen and dissolved i1130 .ul 
benzene containing 25 fl.g dimethlyaminopyridine. To each sam-
ple, 250.uCi [3H)acetic anhydride (10 .ul) and 1.00 .umol unlabeled 
acetic anhydride (10 .ul) was added. The reaction was allowed to 
proceed for 20 h at 25 ° C. Methanol (25? fl.l) w.as added to. destroy 
excess acetic anhydnde and the (3H)dlglycende denvatlVes ex-
tracted by addition of 750 fl.l chloroform/H20 (2 : 1). The chloro-
form extracts were dried and spotted on silica gel 60 TLC plates 
(Whatman LK6), which were developed in toluene: ether (96: 4) 
[21]. 1,2-diacylglycerol acetate (R( 0.28) and 1-ether, 2-acyl glyc-
erol (Rr 0.41) were visualized by iodine vapor and identified by 
comparison to standards. The relative proportion of each was deter-
mined by scraping and counting the appropriate regions of the plate. 
The 1-ether, 2-acyl glycerol acetate spot contained both I-alkyl and 
1-alk-enyl diglyceride species. 
Statistical Analysis Differences in group means of phospholi-
pase C-catalyzed PIP2 hydrolysi.s and 1,2-diradylglycerol content 
among normal, uninvolved, and Il1volved psonatlc epldermls were 
determined by one-way analysis of variance followed by Scheffe's 
multiple comparisons. 
Miscellaneous 1-0-hexadecyl, 2-o1eoylglycerol was prepared 
from 1-0-hexadecyl, 2-o1eoyl phosphatidylcholine by digestion r 
with phospholipase C (B. cereus) a~ described by Conn et al [22). 
DNA and protein content of the epldermal samples were measured 
by the methods of Burton [23] and Lowry et al [24]. respectively. 
Materials [y_32P)ATP (3000 Ci/mol), . 1-[myo-inositol-2-
[3H)PIP2 (2.8 Ci/mmol) and (3Hlacetlc anhydnde (50 mel/mmol) 
were obtained from New England Nuclear (Boston, MA). Phos-
phatidylserine, phosphatidylethanolamine, . cardiolipi~l, a~d 
dioleoy lglycero l were purchased from Avantl Polar LIpIds (Bl~­
mingham, AL). Phosphatidylinositol-4,5-b~sphosphate, phosphati-
dic acid, 1-0-hexadecyl, 2-0leoyl phosphattdylcholll1e, phosphoh-
pase C from B. cereus and trizma base wer~ from Sigma Chemical 
Co. (St. Louis, MO). Octyl-P-D-glucoslde was obtamed fr~m 
Boehringer Mannheim Biochemical (Indianapolis, IN). E. colt dIa-
cylglycerol kinase was from Lipidex, Inc. ~West~eld, New Jersey) . 
Phosphatidic acid (P A) and lysophosphatidlc aCId were purchased 
fr0111 Serdary (Port Huron, MI). All other chemicals were of at least 
reagent grade. 
RESULTS 
Properties ofPhospho9pase C-Catalyzed P~P2 Hydrolysis in 
Normal and Psoriatic-Involved EpidermiS Phospholl1osl-
tide-specific phospholipase C activity was detected in both the solu-
ble (high-speed supernatant) and membrane (high-speed pellet) 
fractions from human epidermis. Phospholipase C was assayed by ltS 
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abiliry to catalyze the formation of [3H]IP3 from [3H]inositol-la-
belled P1P2' IP3 was separated from DAG, the reaction co-product, 
and unhydrolyzed PIP2 by extraction into the aqueous phase of a 
chloroform/methanol : water two-phase system. Analysis by ion-
exchange chromatography revealed that IP) was the m~or water-
soluble reaction product, accounting for 60% of the water soluble 
radioactivity. The remaining radioactiviry was equally distribured 
between IPz and IP (data not shown). There was no difference 
between normal and psoriatic epidermal supernatants with respecr 
to the distribution among the inositol phosphates formed. IP2 and 
IP could arise either by sequential dephosphorylation of IP3 by 
phosphatases or by phospholipase C - catalyzed cleavage of PIP and 
PI formed by dephosphorylation ofPIP2. Because human e]?idermis 
contains phospholipase C activity that hydrolyzes PI [25], it was 
important to distinguish between these alternative pathways. To do 
this, the phosphoinositides in the ch loroform extract of the phos-
pholipase C assay were analyzed by thin-layer chromatograph '. 
Neither [3H]PIP nor [3H]PI were detected. PIP2 accounted for 
greater than 95% of the radioactivity in the chloroform fraction, 
following incubation of(3H)PIPz with epidermal phospholipase C. 
These data indicate that PIP2 is directly hydrolyzed by epidermal 
phospholipase C, giving rise to IP3, which is partially broken dowll 
to IP2 and IP. 
The time course of P1P2 hydrolysis by soluble phospholipase C 
from uninvolved and involved psoriatic epidermis was linear be-
tween 0 and 5 min (Fig 1). When equal amounts of protein from 
uninvolved and involved psoriatic-involved epidermis were as-
sayed, phospholipase C - catalyzed PIP2 hydrolysis was approxi-
mately 4 times greater in psoriatic-involved compared to unin-
volved epidermis. This was observed for all time points between _ 
and 20 min, suggesting that psoriatic-involved epidermis contains a 
greater capacity for P1P2 hydrolysis than uninvolved epidermis. 
This difference could be due to either increased enzymatic activiry 
or increased affinity of phospholipase C from psoriatic epidermis for 
the substrate PIPz. To investigate this, we compared P1P2 hydrol:-
sis by soluble phospholipase C from uninvolved and involved pso-
riatic epidermis at substrate concentrations ranging from 10 co 
130 fl.M (Fig 2A). At each concentration examined , phospholipase 
C- catalyzed P1P2 hydrolysis was greater in psoriatic-involved than 
in uninvolved epidermis. A double reciprocal plot of the initial rates 
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Figure 1. Time course of PIP2 hydrolysis by phospholipase C from unin-
volved and involved psoriatic epidermis. Soluble phospholipase C fmm. 
normal and psoriatic involved epidermis was incubated with (3HjPIP/pI 
(1 : 0.4) ves icles for the indicated times at 30°C. The reaction was stopped by 
addition of 0.3 ml chloroform/ methanol (1 : 2) and {lH)inositol phosphalt'S 
ex tracted as described in Methods. Reactions contained 50 Ilg protein of th 
high-speed supernatant from either normal or psoriatic-involved epidermis. 
Results are from a representative experiment. Similar resu lts were ObrainN 
with tissue from four individuals. 
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Figure 2. PIP2 dependence of soluble phospholipase C from uninvolved and involved psoriatic epidermis. (A) Soluble phospholipase C activity from normal 
and psoriatic involved epidermis (50 /lg protein each) was assayed with [3H]PIP,jPE vesicles at the indicated concentrations ofPIP2. (B) Double reciprocal 
plot o fPIP2 hydrolysis by soluble phospholipase C from uninvolved and involved psoriatic epidermis. T he concentrations ofPIP2 ranged from 100 to 600 .uM. 
Reactio n conditions and quantitation of products were the same as described in the legend to Fig 1. Results are from a representative experiment. Similar results 
were obtained with tissue from four individuals. 
of PIP2 hydrolysis, over the concentration range of 100-600 pM 
PIP2 , revealed that the increased activity in psoriatic-involved com-
pared to uninvolved epidermis was due to an increased V max (70 
nmoljmin/ mg vs 20 nmol/ min/ mg, respectively, Fig 2B). Over 
the concentration range examined, there was no significant differ-
ences in K.", for PIP2 between uninvolved and involved psoriatic 
epidermis (350 pM). 
W e next examined the pH dependence of PIP2 hydrolysis by 
soluble phospholipase C from uninvolved and involved psoriatic 
epidermis. Activity from both types of epidermis displayed similar 
broad maxima between pH 6 and pH 7. At pH 5 and pH 8, activi ty 
was reduced by 65%. At each pH examined, the activity in psori-
atic-involved epidermis was approximately 4 times greater than in 
uninvolved epidermis (data not shown). 
Having characterized phospholipase C-catalyzed PIP2 hydroly-
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sis in the soluble fraction of uninvolved and involved psoriatic epi-
dermis with respect to time, substrate, and pH dependencies, we 
next quantitated the level of .acti~i ty in 11 p~ ired sample~ of i~­
volved and uninvolved psonatlc epidermiS and III normal epidermiS 
from seven individuals (Fig 3A ). This was done in the presence of 
excess calcium (1 mM) to permit full expression of enzymatic activ-
ity. The mean ac tivity in psoriatic-involved epidermis, expressed 
per mg protein, was 3.7 times greater than in uninvolved and n or-
mal epidermis (p < 0.001) . PIP2 hydrol Y515 normahzed to tissue 
DNA was similarly increased in involved versus uninvolved epider-
mis for six paired samples (data not shown) . The activity in unin-
volved psoriatic epidermis was not significantly different from nor-
mal epidermis. 
Phospholipase C-catalyzed PIP2 hydrolysis was also detected in 
the washed particulate frac tion (high-speed pellet) from normal and 
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Figure 3. Hydrolys is of PIP2 by soluble and membrane-associated phospholipase C from normal, psoriatic involved, and psoriatic uninvolved epidermis. (A) 
Soluble phospholipase C activi ty; reactions contained 50.ug protein and 75.uM PIP2 in [3H)PIP2/PE (1: 0.4) vesicles. D ifferences in activities berween 
psoriatic involved and psoriatic uninvolved and berween psoriatic involved and normal epidermis were statistically significant (p < 0.001). Activities in normal 
wd psoriatic-uninvolved epidermis were not significantly different. (B) Membrane-associated phospholipase C activity; reactions contained 20 Ilg protein and 
100 J1.M ['H)PIP2 in PIP2 IPE (1 : 3) vesicles. Differences in group means berween involved and uninvolved (p < 0.004), and between involved and normal (p < 0.002), were statistically significant. Activities in uninvolved and normal epidermis were not statistically significant. 
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psoriatic epidermis. In the presence of 100,uM [~HJPIPz (i~ soni-
cated vesicles composed of PIP 2/PE.1 : 3) actIVIty Increased lInearly 
between 0 and 5 min and was linearly dependent on protein con-
centrations between 10 - 50,ug (data not shown) . In normal epider-
mis. the specific activity of membrane-associated phospholipase C 
was approximately 6 times greater than the soluble activity. al-
though the amount of membrane-associated activity was approxi-
mately 10 times lower than the soluble activity when assayed under 
similar conditions. Quantitative comparison of membrane-asso-
ciated phospholipase C - catalyzed PIPz hydrolysis in normal. unin-
volved. and involved epidermis revealed differences similar to those 
observed in the soluble activity (Fig 3B). Membrane-associated 
phospholipase C activity was elevated approximately 3 times in 
involved psoriatic epidermis compared to uninvolved and normal 
epidermis (p < 0 .004). Activity in normal and uninvolved psoriatic 
epidermis did not differ. 
1,2-Diacylglycerol Content in Normal and Psoriatic Epi-
dermis The finding that phospholipase C-catalyzed P1P2 hydrol-
ysis is significantly elevated in psoriatic-involved epidermis suggests 
that 1.2-diacylglycerol may also be significantly elevated. This may 
have important metabolic consequences because 1.2-diacylglycerol 
is the physiologic activator of protein kinase C. We therefore uti-
lized a two-step procedure to d.et~rmine the conte.nt of 1.2-di~cyl­
glycerol in normal and pSOnatlc-1I1volv~d and umn.volved eplde:-
mis. In the first step. we employed a prevIOusly descnbed enzymatic 
method [19] to quantitate 1.2-diradylglycerol. (1.2-diacylglycerol 
plus I-ether. 2-acyl-glycerol). In the second step, we determined 
the proportion of 1,2-diacyl and I-ether. 2-acyl-glycerol in psori-
atic-uninvolved and involved epidermis . On a per microgram DNA 
basis. 1.2-diradylglycerol content in psoriatic-involved epidermis 
was elevated 3 times compared to uninvolved and normal epidermis 
(p < 0.001) (Fig 4). 1.2-diradylglyc~rol content express~d?n a mil-
ligram protein basis was SImIlarly 1I1creased 111 psonauc-11l.volved 
epidermis (p < 0.02). There was no slgmficant difference. 111 1.~­
diradylglycerol content between normal an~ un1l1volved epIdermIS. 
In uninvolved psoriatic epidermis. 1.2-dlacylglycerol accounted 
for 86% of the 1.2-diradylglycerol (Table f). In psoriatic involved 
epidermis, 95% of the 1.2-diradylglycerol was 1,2-diacylglycerol. 
These data demonstrate that the vast majority of increased 1,2-dira-
dylglycerol observed in psoriatic involved epidermis (Fig 4) is com-
posed of 1.2-diacylglycerol. 
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Figure 4. Content of 1.2-diradylglycerol in normal, psoriatic-involved. 
and psoriatic-uninvolved epidermis. Epidermal samples . (approxImately 
300 mg wet weight) were obtalllcd by keratome bIOpsy, TIssue hInds were 
extracted in chloroform/methanol and 1.2-diradylglycerol quantitated by 
enzymatic conversion to [J2P]phosphatidic acid as described in Methods. The 
amount of 1.2-diradylglycerol in the tissues was normalIzed to DNAan.d 
protein content. Psoriatic involved versus psoriatic uninvolved and psonatlc 
involved versus normal were significantly dIfferent (p < 0.002 on DNA 
basis; p < 0.01 on protein basis). Psoriatic-uninvolved versus normal epIder-
mis was not significantly different. 
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Table I. Proportion of 1-Acyl and 1-Ether 1.2-Diglycerides in 
Univolved and Involved Psoriatic Epidermis· 
Diglyceride 
1.2-diacyl 
I-ether. 2-acy I 
0/0 of Toral (CPM) 
Uninvolved (n = 5) 
85.6 ± 2.5 
14.4 ± 2.5 
Involved (n = ') 
94.8 ± 1.8 
5.2± 1.8 
• 1.2-diglyceride was extracted from psoriatic-involved and uninvolved epidermis 
approximately (300 mg wet weight) and isolated by thin-layer chromatography. Tilt 
1.2-diglyceride was further fractionated into 1.2-diacyl and I-ether. 2-acyl diglyc~cks 
following derivatization with ['H) acetic anhydride. The proportion of each species~ 
1.2-diglyceride was determined by scraping and counting the appropriate region of tht 
plate. Values are expressed as mean ± SD. 
Activation of Epidermal Protein Kinase C by Epidermal 1,2. 
Diacylglycerol Cellular 1.2-diacylglycerol contains a m1x£11It" 
of different fatty acyl chains attached to the sn-1 and 5n-2 posi tion.; 
of the glycerol backbone. These fatty acyl chains differ in bo 
number of carbons and degree of un5aturation. 1.2-diacylglycero1 
containing unsaturated acyl groups have been shown to preferen-
tially activate protein kinase C compared to saturated species [26t 
The above data demonstrate that 1,2-diacylglycerol content is si_-
nificantiy increased in psoriatic-involved epidermis compared 
uninvolved and normal epidermis. This may lead to activation o· 
protein kinase C in psoriatic lesions. To investigate this possibili -, 
we determined the ability of 1.2-diradylglycerol (which is predomi-
nantly 1.2-diacylglycerol) purified from normal and psoriatic-in-
volved epidermis to activate epidermal protein kinase C in vi 
Protein kinase C was partially purilied from normal human epider, 
mis and assayed in the presence of calcium plus phosphatidylserin 
alone and with equal amouim of either 1 ,2-dioleoylglycerol (1.2-di-
acyl glycerol containing two 18-carbon acyl chains. each with on~ 
unsaturated bond) or 1.2-diradylglycerol from normal or psoriari _ 
involved epidermis. Very little activity was observed in the presenct-
of calcium plus phosphatidylserine alone. Addition of 1 . 
dioleoylglycerol or 1.2-diradylglycerol from either normal or pso-
riatic-involved epidermis stimulated protein ~i~as~ C activity. (Fig 
5). 1.2-diradylglycerol from normal and psonatlc-ll1volved eplder-
7 
":' 
0 6 
>< 
E 5 
c. 
~ 4 
> ~ 
:> 3 i= 
c.J 
<t 2 
c.J 
~ 
0. 
O 
PS PS/OO PS/OG 
Figure 5. Activation o( epidermal protein kinase C by 1.2-diradylgly . 
from normal and psoriatic involved epidermis. 1.2-diradylglycerol W:IS tI-
tracted (rom normal and psoriatic involved epidermis and purified by thin-
layer chromatography. Protein kinase C was partially purified from nonm. 
epidermis [16). Dioleoylglycerol (DO) or epidermal 1.2-diradylgly 
(DG) was mixed with phsophatidylserine (PS) in chlorofonn. dried un 
stream ofN2 • resuspended in 20 mM Tris (pH 7.4). and sonicated. Com , 
reaction mixtures contained 2 J1g phosphatidylserine. 0.4 J1g dioleoylg . "-
erol or epidermal 1.2-diradylglycerol. 100 J.1m Ca++ and 20 J.1g protein . 
nase C in a total of 0.2 m!. Protein kinase C was assayed as described ' 
Methods. Filled bars, DG from normal epidermis; striped bars. DG from 
atie involved epidermis. Each bar is for DG obtained from one individ 
VOL. 95, NO.4 OCTOBER 1990 
nUs were equally effective in stimulating activity, but were less 
effective than 1,2-dioleoylglycerol. Stimulation of protein kinase C 
from normal epidermis by 1,2-diradylglycerol from normal or pso-
riatic-involved epidermis was approximately 50% of that observed 
with 1,2-dioleoylglycerol. Presumably, protein kinase C from nor-
ma! epidermis and psoriatic lesions respond similarly to 1,2-diacyl-
glycerol, although this was not examined. 
Down-Regulation of Epidermal Protein Kinase C In intact 
cells, activation of protein kinase C by TP A causes translocation of 
the enzyme from the cytosol to the membrane, where it is activated. 
This is followed by loss of protein kinase C activity due to incre.ased 
susceptibility of the activated enzyme to proteolytic degradation. 
The decrease in protein kinase C activity following its activation is 
termed down-regulation. In vitro 1,2-diacylglycerol also promotes 
proteolysis of protein kinase C [27], but whether it is able to do so to 
the same extent as TPA in intact cells is less well established. To 
investigate whether down-regulation of protein kinase C can po-
tenrially occur in human epidermis, fresh keratome biopsies were 
placed stratum corneum-up in petri dishes and treated topically with 
TPA, 1,2-diacylglycerol (1,2-dioctanoylglycerol), or vehicle (eth-
anol) . The synthetic l,2-diacylglycerol, l,2-dioctanoylglycerol, 
was utilized because it is able to pass throug h the outer leaflet of the 
surface membrane due to its relatively short 8-carbon acyl chains. 
Naturally occurring l,2-diacylglycerol containing acyl chains of12 
or more carbons are unable to do so. Following 30 min exposure to 
TPA, total protein kinase C activity was reduced 5 times (Fig 6). 
l,2-diacylglycerol (l,2-dioctanoylglycerol) also caused a dose-de-
pendent decrease in total protein kinase C activity. The reduction in 
protein kinase C activity caused by the highest concentration of 
l,2-diacylglycerol (5 mM) was similar to that observed with a 1000 
times lower concentration ofTPA (5 ,uM) . The higher concentra-
tion of l,2-diacylglycerol required for maximal effect compared to 
TPA is consistent with the relative potencies of these two com-
pounds to activate epidermal protein kinase C [16). 
We next investigated whether the reduction in protein kinase C 
activity could be blocked by protease inhibitors. For these studies, 
keratome biopsies were treated for 10 min with TPA (5 ,uM) in the 
presence or absence of protease inhibitors and soluble and mem-
brane-associated protein kinase C activities separately determined. 
Addition ofTPA caused decreased protein kinase C activity in both 
the soluble and membrane fractions (Fig 7). Loss of soluble activity 
300 
250 
0.05 mM 
CTRL. TPA L DIOCTANOYLGL YCEROL ---1 
Figure 6. Down-regulation of epidermal protein kinase C by phorbol ester 
md 1,2-diacylglycerol. Keratome biopsies from normal human skin were 
placed stratum corneum side-up in petri dishes containing a thin layer of 
Macoy's SA media. TPA and l,2-dioctanoylglycerol in ethanol were applied 
in a volume of 50 III to uniformly cover the surface of the stratum corneum. 
The biopsies were incubated at 37"C for 30 min and then snap frozen in 
liquid nitrogen. Total protein kinase C was extracted from the tissue and 
2Ssayed as described in Methods. Control tissue was treated with 50 III ethanol 
alone. Results are means ± SEM from four experiments. 
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Figure 7. The effect of protease inhibitors on protein kinase C down-regu-
lation in human epidermis. Keratome biopsies from normal human skin 
were treated, as described in the legend to Fig 6, with TPA, in the presence Or 
absence of the protease inhibitors chymostatin (chym), antipain (antp), Or 
leupeptin (leup) . The protease inh ibitors were added to a concentration of 1 
mg/ tnl in the media the biopsies were bathed in. The biopsies were incu-
bated in this media at room temperature for 15 min prior to addition ofTPA 
(SliM) for 10 min at 37°C. Following this, the biopsies were snap frozen in 
liquid nitrogen and soluble (OpCll bars) and membrane-associated (stippled 
bars) protein kinase C activities extracted from the tissue and assayed as 
described in Methods. Results are means ± SEM from four experiments. 
was unaffected by the presence of the protease inhibitors chymo-
statin, antipain, or leupeptin. This is consistent with the loss of 
soluble activity being due to translocation of protein kinase C to the 
membrane, which would not be expected to be sensitive to protease 
inhibition. In contrast to the soluble fraction, the reduction in 
membrane-associated activity following TPA treatment was par-
tially blocked by each of the protease inhibitors. This finding sug-
gests that loss of membrane-associated protein kinase C activity may 
involve proteolytic degradation. The data in Figs 6 and 7 indicate 
that the protein kinase C activators TPA and l,2-diacylglycerol 
promote down-regulation of protein kinase C in human epidermis. 
DISCUSSION 
Both soluble and membrane-associated phospholipase C-catalyzed 
PIP2 hydrolys is were elevated 3 times in fsoriatic-involved epider-
mis compared to uninvolved and norma epidermis. Bergers et al 
have also reported increased membrane-associated phospholipase C 
in psoriatic epidermis [28). Using PI as substrate, Bartel et al [25) 
found a significant elevation of phospholipase C activity, in low-
speed supernatants from psoriatic-involved compared to uninvolved 
and normal epidermis. Multiple forms of phosphoinositide-specific 
phospholipase C have been identified in several tissues. In brain, at 
least three isozymes of phosphoinositide-specific phospholipase C 
exist. Each isozyme displays varying degrees of membrane associa-
tion and selectivity toward PI and PIP2 [29-32). The composition 
and properties of phospholipase C isozymes in human epidermis is 
currently unknown and therefore whether a single phospholipase C 
species is responsible for the demonstrated increases in the PI and 
PIP2-hydrol yzing ac tivities in psoriatic-involved epidermis is un-
known. 
Recent evidence suggests that 1,2-diacy lglycerol, which is 
formed in response to agonist activation, may arise from phospho-
lipid head-group classes other than phosphoinositides. Kennerly has 
observed that the molecular species of 1,2-diacylglycerol that accu-
mulate in mas t cells following stimulation with IgE are not preferen-
tially entiched in arachidonic acid as would be expected if they were 
formed from hydrolysis of phosphoinositides [33). Rather, the 
434 FISHER ET AL 
1,Z-diacylglycerol is composed primarily of molecular species con-
taining one or two double bonds, similar to the composition of 
phosphatidylcholine. Thus, although IgE stimulates phospholipase 
C-catalyzed PIPz hydrolysis and accumulation of 1,Z-diacylglyc-
erol, a significant portion of the 1,Z-diacylglycerol formed may be 
derived from the hydrolysis of phosphatidylcholine. Evidence sug-
gests that ago nist-induced breakdown of phosphatidylcholine, cata-
lyzed by phospholipase C and/or phospholipase D, may lead to 
elevations in 1,Z-diacylglycerol in a variety of cells [34 -36]. Pre-
sumably, in agonist-stimulated cells, 1,Z-diacylglycerol formed 
from ei ther inositol- or choline-containing phospholipids is capable 
of activating protein kinase C. Thus, although phospholipase C-ca-
talyzed hydrolysis of phosphoinositides is one pathway for the gen-
eration of 1,2-diacylglycerol, it may not be the sole source of the 
increased 1,Z diacylglycerol in psoriatic lesions. 
Keratinocytes comprise approximately 90% of the cells in a kera-
tome biopsy and presumably are the cellular source of the observed 
elevations in the activi ty of phospholipase C-catalyzed PIPz hydrol-
ysis and 1,2-diacylglycerol content in psoriatic plaque. Some con-
tribution to the observed elevations by immune cells in psoriatic 
lesions, however, cannot be ruled out. Both neutrophils and lym-
phocytes contain phospholipase C activities that hydrolyze PIPz 
l37 - 39], and activation of these cells leads to increased 1,Z-diacyl-
glycerol content [39 - 41] . Although it is difficult to directly com-
pare separate studies due to differences in assay methods, it appears 
from the available literature that the activity of phospholipase C-
catalyzed PIPz hydrolysis in immune cells is similar to that found in 
normal epidermis. Therefore, the contribution of immune cells to 
the phospholipase C activity in psoriatic lesions is probably rela-
tively little, because immune cells comprise only approximately 5% 
of the cells in a keratome biopsy. The content of 1,Z-diacylglycerol 
in keratinocytes [4Z] and immune cells is also similar and therefore 
the contribution of immune cells to the observed increase in 1,Z-di-
acylglycerol in psoriatic lesions is also likely to be minor. 
Evidence suggests that the phospholipase C/protein kinase C 
signal transduction system in epidermis participates in the regula-
tion of release of pro-inflammatory eicosanoids [43,44] and inter-
leukin-1 [45,46]' induction of epidermal transglutaminase activity 
and formation of cross-linked envelopes [13,14]. Additionally, 
1,Z-diacylglycerol has been shown to be a chemoattractant for neu-
trophils and lymphocytes [47,48] and may therefore promote in-
traepidermal infiltration of these cells. The inflammation and in-
creased cross-linked envelope formation, observed in psoriasis [49] , 
may therefore reflect, in part, responses of psoriatic epidermis to 
phospholipase C activation. 
The findings that the activi ty of phospholipase C-catalyzed PIPz 
hydrol ysis and 1 ,Z-diacy lglycerol content are significantly elevated 
in psoriatic lesions and that the lesional 1 ,Z-diacylglycerol is capable 
of activating protein kinase C from normal epidermis in vitro lead 
us to specul ate that a state of chronic activation of the phospholipase 
C/protein kinase C signal transduction system may exist in psoriatic 
lesions. This, however, may not be the case, because the total 
amount of protein kinase C capable of being activated by 1,Z-diacyl-
glycerol is significantly reduced in psoriatic lesions [50] . This re-
duction, however, is not necessarily incompatible with a state of 
activation, because addition of activators of protein kinase C such as 
TPA or 1,Z-diacylglycerol (1 ,Z-dioctanoylglycerol) to epidermal 
slices caused a rapid decrease (within 30 min) in total protein kinase 
C activity (Fig 6). Similar effects ofTPA on protein kinase C activ-
ity have been observed in a variety of cell types including rat [51] 
and human [5Z] keratinocytes. Following exposure to TPA or 
1 ,Z-diacylglycerol, soluble protein kinase C is decreased as a result 
of membrane-association, where the enzyme interacts with TPA or 
1,Z-diacylglycerol and becomes activated. Following this, the ac ti-
vated, membrane-associayed enzyme may be proteolytically de-
graded. Membrane association with 1,Z-diacylglycerol is known to 
enhance the susceptibility of protein kinase C to proteolysis by a 
neutral calcium-activated protease (cal pain) [Z7] . Cal pain activity is 
found in most tissues and is quite abundant in epidermis [53]. Addi-
tion of the cal pain inhibitors antipain and leupeptin partially 
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blocked the TPA-induced decrease in protein kinase C activity (Fio 
7), suggesting that cal pain-mediated down-regulation of activated 
protein kinase C occurs in human epidermis. 
It is conceivable that protein kinase C activity in psoriatic 
lesions may be decreased due to reduced synthesis, and that 1,2-diac-
ylglycerol is increased to compensate for this to attempt to achieve 
an optimal level of protein kinase C activation. At present, however 
there exists no evidence to support such a mechanism. Alternatively, 
the decreased protein kinase C activity in psoriatic lesions may be 
due to activation of the enzyme by 1,Z-diacylglycerol and subse-
quent down-regulation. The demonstration that 1,Z-diac-
ylglycerol-induced down-regulation of protein kinase C occurs in 
human epidermis and that phospholipase C activity and 1,Z-diacyl-
glycerol content are elevated in psoriatic lesions favors, but does nor 
prove, this possibility. 
We would like to thallk Ms. CarolYII PeterseII,jellelda Ly"ch, alld Virgillia Harris 
for their technical assista llce and Ms. Clalidia Hagedoll for preparatioll of the manl/-
script. 
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